If you have not heard of peripheral artery disease, or PAD, you are not alone. While clinicians and health organizations have made headway in raising awareness that heart disease is the No. 1 cause of ...
On the heels of STRIDE, one of the first trials to show glucagon-like peptide-1 (GLP-1) receptor agonists can help patients with PAD, a retrospective study of more than 100,000 patients provides more ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) who also have atrial fibrillation (AFib) face a significantly higher risk ...
Hosted on MSN
Patients with peripheral arterial disease and Afib found to face higher risk for cardiac events
Credit: Intermountain Health New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) who also have atrial fibrillation (AFib) face ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results